Soluble CD40L stimulation human peripheral blood B cell long-period culture method

A technology of human peripheral blood and culture methods, applied in blood/immune system cells, tissue culture, animal cells, etc., can solve the problems of high cost, increased interference factors, and low efficiency of dendritic cell culture in vitro

CN101041815BInactive Publication Date: 2011-06-01THE AFFILIATED DRUM TOWER HOSPITAL MEDICAL SCHOOL OF NANJING UNIV
0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Publication Date
2011-06-01
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention discloses a long-term culturing method with soluble CD40 ligand (sCD40L) to stimulate human peripheral blood B cell, which comprises the following steps: asepsis-collecting human peripheral blood; separating human peripheral blood from separating liquid of lymphocyte; placing individual nuclear cell of human peripheral blood in culturing liquid of 10% human AB serum, transferring and insulin; hanging load cell; putting into incubator to culture; adding into 2ug / ml 1L-4 of sCD40L, CsA 625ug / ml and 2ng / ml; stimulating the culture continually. The active B cell can high express MHCI, MHC II, CD80, CD86 and so on necessary molecular with submitting antigen, which can effectively submit tumour cell cracking matter, antigen peptide, antigen cDNA and RNA to induce immune response of specificity cell.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to a cell culture method, in particular to a long-term culture method using soluble CD40 ligand (sCD40L) to stimulate human peripheral blood B cells. Background technique

[0002] In the field of anti-HBV-specific active immunotherapy, dendritic cells (DC), as a powerful antigen-presenting cell (APC), play a central role in anti-viral immunity. Scientific research has proved that DC functional defects or reduced numbers are directly related to chronic hepatitis B or chronic carrier status. Therefore, the use of activated DC can induce HBsAg-specific killing effect, which is a very promising method for active immunotherapy against hepatitis virus. However, this method has the following defects: (1) the number of dendritic cells is very small in a natural state, only accounting for 0.1%-0.5% of peripheral blood mononuclear cells, and it is difficult to culture in vitro, and the survival time is short. In 10-15 days, the number of ...

Examples

Embodiment Construction

[0017] i. Aseptically collect 20ml of human peripheral blood (PBMC) (anticoagulant), resuspend with IMDM culture medium, and count;

[0018] ii. Centrifuge at 1500 rpm for 5 minutes at room temperature, remove the supernatant;

[0019] iii. Resuspend cells with culture medium and count;

[0020] iv. The culture solution contains 10% human AB serum, transferrin, insulin;

[0021] v. Separate human peripheral blood mononuclear cells with ficoll, and culture them;

[0022] vi. Adjust the concentration of human peripheral blood mononuclear cells to 2×106 / ml, culture system: 4ml;

[0023] vii. Add IL-4 2ng / ml, CsA 625ug / ml, sCD40L 2ug / ml to the culture medium;

[0024] viii. Transfer the PBMC suspension to a 6-well culture plate, add 4ml to each well (2×10 6 / ml);

[0025] ix. Put it into an incubator with 5% CO2, 37°C and saturated humidity for cultivation;

[0026] x. The human peripheral blood mononuclear cells were allowed to stand for more than 12 hours, and when the cel...